We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV.
- Authors
Ling Wang; Juan Zhao; Schank, Madison; Hill, Addison C.; Banik, Puja; Yi Zhang; Wu, Xiao Y.; Lightner, Janet W.; Ning, Shunbin; El Gazzar, Mohamed; Moorman, Jonathan P.; Yao, Zhi Q.
- Abstract
Despite effective control of HIV replication by antiretroviral therapy (ART), a significant number of people living with HIV (PLWH) fail to achieve complete immune reconstitution and thus are deemed immune non-responders (INRs). Compared with immune responders (IRs) who have restored their CD4 T cell numbers and functions, CD4 T cells from these INRs exhibit prominent mitochondrial dysfunction and premature aging, which play a major role in increasing the incidence of non-AIDS, non-communicable diseases (NCDs). To date, there are no reliable biomarkers that can be used to typify and manage PLWH, especially INRs with non-AIDS NCDs. Growth differential factor-15 (GDF-15) is a transforming growth factor-β (TGF-β) family member known to regulate several biological processes involved in cell aging and stress responses. Since PLWH exhibit premature aging and metabolic dysregulation, here we measured the plasma levels of GDF-15 by ELISA and metabolic proteins by proteomic array and correlated the results with clinical parameters in ARTcontrolled PLWH (including INRs and IRs) and healthy subjects (HS). We found that GDF-15 levels were significantly elevated in PLWH compared to HS. GDF-15 levels were positively correlated with age and negatively associated with body mass and LDL cholesterol levels in the study subjects. Also, elevated GDF-15 levels were correlated with differential dysregulation of multiple metabolic proteins in PLWH. These results suggest that GDF-15 protein may serve as a biomarker of metabolic dysregulation and aging, and this biomarker will be useful in clinical trials targeting aging and metabolic disorders in ART-treated PLWH.
- Subjects
METABOLIC disorders; ANTIRETROVIRAL agents; T cells; RESEARCH funding; HIV-positive persons; CELLULAR aging; ENZYME-linked immunosorbent assay; IMMUNE system; LDL cholesterol; HEALING; NON-communicable diseases; GROWTH factors; AGING; PROTEOMICS; ONE-way analysis of variance; BIOMARKERS; TRANSFORMING growth factors-beta
- Publication
Frontiers in Aging Neuroscience, 2024, p1
- ISSN
1663-4365
- Publication type
Article
- DOI
10.3389/fragi.2024.1414866